Study shows better asthma relief from combo therapy

05/23/2007 | Forbes

New data shows AstraZeneca's combination asthma treatment Symbicort improved quality of life and satisfaction for patients better than the drug's two main ingredients do separately. Symbicort, recently approved for long-term use, is a combination of the inhaled corticosteroid budesonide and the beta agonist formoterol fumarate dehydrate.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC